XML 28 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
 
Recurring fair value measurements
 
The following tables present the Company’s financial assets and liabilities carried at fair value on a recurring basis by fair value hierarchy category:

Assets and liabilities measured at
fair value on a recurring basis
 
September 30, 2018
 
Quoted prices
in active
markets for
identical assets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
Assets
 

 
 

 
 

 
 

Fixed maturities available-for-sale:
 

 
 

 
 

 
 

U.S. government direct obligations and U.S. agencies
$


$
1,426,095


$


$
1,426,095

Obligations of U.S. states and their subdivisions


1,959,125




1,959,125

Corporate debt securities


15,331,285


8,623


15,339,908

Asset-backed securities


1,568,739




1,568,739

Residential mortgage-backed securities


75,247




75,247

Commercial mortgage-backed securities


1,245,498




1,245,498

Collateralized debt obligations


935,690




935,690

Total fixed maturities available-for-sale

 
22,541,679


8,623


22,550,302

Fixed maturities held-for-trading:
 


 


 




U.S. government direct obligations and U.S. agencies


137,866




137,866

Corporate debt securities


3,044




3,044

Commercial mortgage-backed securities


1,033




1,033

Total fixed maturities held-for-trading

 
141,943




141,943

Short-term investments
369,539


45,650




415,189

Limited partnership interests (1)

 

 

 
71,895

Equity investments
38,374

 
5,400

 

 
43,774

Collateral under securities lending agreements


66,784




66,784

Collateral under derivative counterparty collateral agreements
51,090






51,090

Derivative instruments designated as hedges:
 


 


 




Interest rate swaps


5,037




5,037

Cross-currency swaps

 
31,025

 

 
31,025

Derivative instruments not designated as hedges:
 


 


 




Interest rate swaps


681




681

Interest rate swaptions


164




164

Other forward contracts


976




976

Cross-currency swaps


22,435




22,435

Total derivative instruments

 
60,318

 

 
60,318

Embedded derivatives - GLWB

 

 
6,849

 
6,849

Separate account assets (1)
15,781,604


9,915,781




26,142,156

Total assets
$
16,240,607


$
32,777,555


$
15,472


$
49,550,300

Liabilities
 


 


 


 

Payable under securities lending agreements
$


$
66,784


$


$
66,784

Collateral under derivative counterparty collateral agreements
11,960

 

 

 
11,960

Derivative instruments designated as hedges:
 


 


 




Cross-currency swaps


37,542




37,542

Derivative instruments not designated as hedges:
 


 


 




Interest rate swaps


943




943

Other forward contracts


6,060




6,060

Cross-currency swaps


28,839




28,839

Total derivative instruments

 
73,384

 

 
73,384

Separate account liabilities (2)


217,062




217,062

Total liabilities
$
11,960

 
$
357,230

 
$


$
369,190

 
 
 
 
 
 
 
 
(1) Included in the total fair value amount are $445 million of separate account assets and $72 million of limited partnership interests as of     September 30, 2018 for which the fair value is estimated using net asset value per unit as a practical expedient.
 (2) Includes only separate account instruments which are carried at the fair value of the underlying liabilities owned by the separate accounts.

Assets and liabilities measured at
fair value on a recurring basis
 
December 31, 2017
 
Quoted prices
 
Significant
 
 
 
 
 
in active
markets for
identical assets
(Level 1)
 
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
Assets
 


 


 


 

Fixed maturities available-for-sale:
 


 


 


 

U.S. government direct obligations and U.S. agencies
$


$
1,871,642


$


$
1,871,642

Obligations of U.S. states and their subdivisions


2,090,972




2,090,972

Corporate debt securities


15,696,349


9,738


15,706,087

Asset-backed securities


1,717,976




1,717,976

Residential mortgage-backed securities


64,984




64,984

Commercial mortgage-backed securities


1,357,609




1,357,609

Collateralized debt obligations


783,869




783,869

Total fixed maturities available-for-sale

 
23,583,401

 
9,738


23,593,139

Fixed maturities held-for-trading:
 


 


 




U.S. government direct obligations and U.S. agencies


16,836




16,836

Corporate debt securities


3,156




3,156

Commercial mortgage-backed securities


1,067




1,067

Total fixed maturities held-for-trading

 
21,059




21,059

Short-term investments
288,302


61,964




350,266

Collateral under derivative counterparty collateral agreements
57,820






57,820

Derivative instruments designated as hedges:
 


 


 




Interest rate swaps


7,476




7,476

Cross-currency swaps

 
19,958

 

 
19,958

Derivative instruments not designated as hedges:
 


 


 




Interest rate swaps


3,530




3,530

Interest rate swaptions


75




75

Cross-currency swaps


20,320




20,320

Total derivative instruments

 
51,359




51,359

Separate account assets (1)
16,523,630


10,736,532




27,660,571

Total assets
$
16,869,752


$
34,454,315


$
9,738


$
51,734,214

Liabilities
 


 


 


 

Collateral under derivative counterparty collateral agreements
$
5,490

 
$

 
$

 
$
5,490

Derivative instruments designated as hedges:
 


 


 




Cross-currency swaps


51,316




51,316

Derivative instruments not designated as hedges:
 


 


 




Interest rate swaps


1,628




1,628

Cross-currency swaps


41,599




41,599

Total derivative instruments

 
94,543

 

 
94,543

Embedded derivatives - GLWB

 

 
11,095

 
11,095

Separate account liabilities (2)
8


409,266




409,274

Total liabilities
$
5,498

 
$
503,809

 
$
11,095

 
$
520,402

 
 
 
 
 
 
 
 
(1) Included in the total fair value amounts are $400 million of investments as of December 31, 2017 for which the fair value is estimated using net asset value per unit as a practical expedient.
 (2) Includes only separate account instruments which are carried at the fair value of the underlying liabilities owned by the separate accounts.

The methods and assumptions used to estimate the fair value of the Company’s financial assets and liabilities carried at fair value on a recurring basis are as follows:

Fixed maturity investments
 
The fair values for fixed maturity investments are generally based upon evaluated prices from independent pricing services.  In cases where these prices are not readily available, fair values are estimated by the Company. To determine estimated fair value for these instruments, the Company generally utilizes discounted cash flow models with market observable pricing inputs such as spreads, average life, and credit quality. Fair value estimates are made at a specific point in time, based on available market information and judgments about financial instruments, including estimates of the timing and amounts of expected future cash flows and the credit standing of the issuer or counterparty.

Equity investments
 
The fair value for equity securities is generally based upon quoted market prices in active markets for identical assets
that the Company has the ability to access. 
 
Short-term investments and securities lending agreements
 
The amortized cost of short-term investments, collateral under securities lending agreements, and payable under securities lending agreements is a reasonable estimate of fair value due to their short-term nature and high credit quality of the issuers. Short-term investments also include money market funds that are valued using unadjusted quoted prices in active markets.
 
Derivative counterparty collateral agreements
 
Included in other assets is cash collateral received from or pledged to derivative counterparties and included in other liabilities is the obligation to return the cash collateral to the counterparties.  The carrying value of the collateral is a reasonable estimate of fair value.
 
Derivative instruments
 
Included in other assets and other liabilities are derivative financial instruments. The estimated fair values of OTC derivatives, primarily consisting of cross-currency swaps, interest rate swaps, interest rate swaptions, and other forward contracts, are the estimated amounts the Company would receive or pay to terminate the agreements at the end of each reporting period, taking into consideration current interest rates and other relevant factors.

Embedded derivative - GLWB

Significant unobservable inputs used in the fair value measurements of GLWB include long-term equity and interest rate implied volatility, mortality, and policyholder behavior assumptions, such as benefit utilization, lapses, and partial withdrawals.

Limited partnership interests
 
Limited partnership interests represent the Company’s minority ownership interests in pooled investment funds. These funds employ varying investment strategies that primarily make private equity investments across diverse industries and geographical focuses. The net asset value, determined using the partnership financial statement reported capital account adjusted for other relevant information which may impact the exit value of the investments, is used as a practical expedient to estimate fair value. Distributions by these investments are generated from investment gains, from operating income generated by the underlying investments of the funds, and from liquidation of the underlying assets of the funds which are estimated to be liquidated over the next one to 10 years. In the absence of permitted sales of its ownership interest, the Company will be redeemed out of the partnership interests through distributions.
Separate account assets and liabilities
 
Separate account assets and liabilities primarily include investments in mutual funds, unregistered funds, most of which are not subject to redemption restrictions, fixed maturity, and short-term securities.  Mutual funds and unregistered funds are recorded at net asset value, which approximates fair value, on a daily basis. The fixed maturity and short-term investments are valued in the same manner, and using the same pricing sources and inputs as the fixed maturity and short-term investments of the Company.
 
The following tables present additional information about assets and liabilities measured at fair value on a recurring basis and for which the Company has utilized Level 3 inputs to determine fair value:
 
Recurring Level 3 financial assets and liabilities
 
Three Months Ended September 30, 2018
 
Assets
 
Assets/(Liabilities)
 
Fixed maturities available-for-sale
 
Embedded derivatives
- GLWB
 
Corporate debt securities
 
 
Balances, July 1, 2018
$
8,970

 
$
(513
)
Realized and unrealized gains (losses) included in:
 

 
 
Net income (loss)

 
7,362

Other comprehensive income (loss)
105

 

Settlements
(452
)
 

Balances, September 30, 2018
$
8,623

 
$
6,849

Total gains (losses) for the period included in net income attributable to the change in unrealized gains and losses relating to assets and liabilities held at September 30, 2018
$

 
$
7,362


 
Recurring Level 3 financial assets and liabilities
 
Three Months Ended September 30, 2017
 
Assets
 
Assets/(Liabilities)
 
Fixed maturities 
available-for-sale
 
Embedded derivatives - GLWB
 
Corporate debt securities
 
 
Balances, July 1, 2017
$
10,703

 
$
(9,595
)
Realized and unrealized gains (losses) included in:
 

 
 
Net income (loss)

 
(626
)
Other comprehensive income (loss)
166

 

Settlements
(432
)
 

Transfers out of Level 3 (1)
(357
)
 

Balances, September 30, 2017
$
10,080

 
$
(10,221
)
Total gains (losses) for the period included in net income attributable to the change in unrealized gains and losses relating to assets and liabilities held at September 30, 2017
$

 
$
(626
)
 
 
 
 
 (1) Transfers out of Level 3 are due primarily to increased observability of inputs in valuation methodologies as evidenced by corroboration of market prices with multiple pricing vendors.
 
Recurring Level 3 financial assets and liabilities
 
Nine Months Ended September 30, 2018
 
Assets
 
Assets/(Liabilities)
 
Fixed maturities available-for-sale
 
Embedded derivatives - GLWB
 
Corporate debt securities
 
 
Balances, January 1, 2018
$
9,738

 
$
(11,095
)
Realized and unrealized gains (losses) included in:
 

 
 
Net income (loss)

 
17,944

Other comprehensive income (loss)
221

 

Settlements
(1,336
)
 

Balances, September 30, 2018
$
8,623

 
$
6,849

Total gains (losses) for the period included in net income attributable to the change in unrealized gains and losses relating to assets and liabilities held at September 30, 2018
$

 
$
17,944


  
 
Recurring Level 3 financial assets and liabilities
 
Nine Months Ended September 30, 2017
 
Assets
 
Assets/(Liabilities)
 
Fixed maturities 
available-for-sale
 
Embedded derivatives - GLWB
 
Corporate debt securities
 
 
Balances, January 1, 2017
$
11,639

 
$
(5,712
)
Realized and unrealized gains (losses) included in:
 

 
 
Net income (loss)

 
(4,509
)
Other comprehensive income (loss)
83

 

Settlements
(1,275
)
 

Transfers out of Level 3 (1)
(367
)
 

Balances, September 30, 2017
$
10,080

 
$
(10,221
)
Total gains (losses) for the period included in net income attributable to the change in unrealized gains and losses relating to assets and liabilities held at September 30, 2017
$

 
$
(4,509
)
 
 
 
 
 (1) Transfers out of Level 3 are due primarily to increased observability of inputs in valuation methodologies as evidenced by corroboration of market prices with multiple pricing vendors.

The following table presents significant unobservable inputs used during the valuation of certain liabilities categorized within Level 3 of the recurring fair value measurements table:
 
 
 
 
 
 
Range
 
 
Valuation Technique
 
Unobservable Input
 
September 30, 2018
 
December 31, 2017
Embedded derivatives - GLWB
 
Risk neutral stochastic valuation methodology
 
Equity volatility
 
15% - 30%
 
15% - 30%
 
 
 
 
Swap curve
 
2.40% - 3.16%
 
1.69% - 2.54%
 
 
 
 
Mortality rate
 
Based on the Annuity 2000 Mortality Table
 
Based on the Annuity 2000 Mortality Table
 
 
 
 
Base Lapse rate
 
1% - 15%
 
1% - 15%
Fair value of financial instruments
 
The following tables summarize the carrying amounts and estimated fair values of the Company’s financial instruments and investments not carried at fair value on a recurring basis:
 
September 30, 2018
 
December 31, 2017
 

 

 
Fair value
 

 

 
Fair value
 
Carrying
 
Estimated
 
hierarchy
 
Carrying
 
Estimated
 
hierarchy
 
amount
 
fair value
 
level
 
amount
 
fair value
 
level
Assets
 

 
 

 
 
 
 

 
 

 
 
Mortgage loans on real estate
$
4,365,189

 
$
4,254,101

 
2
 
$
4,005,187

 
$
4,066,800

 
2
Policy loans
4,103,408

 
4,103,408

 
2
 
4,104,094

 
4,104,094

 
2
Limited partnership interests (1)

 

 

 
43,281

 
45,009

 

Other investments
10,840

 
40,387

 
3
 
11,507

 
41,588

 
3
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 
 
 

 
 

 
 
Annuity contract benefits without life contingencies
$
12,882,915

 
$
12,503,021

 
2
 
$
12,704,401

 
$
12,647,309

 
2
Policyholders’ funds
239,576

 
239,576

 
2
 
280,578

 
280,578

 
2
Commercial paper
99,692

 
99,692

 
2
 
99,886

 
99,886

 
2
Notes payable
564,119

 
612,828

 
2
 
543,338

 
581,097

 
2
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) The fair value of limited partnership interests as of December 31, 2017 is estimated using net asset value per unit as a practical expedient.